Definitive Healthcare Corp.
Close on Oct 19, 2026
- Market cap
- $116.39M
- P/E (TTM)
- –
- Dividend yield
- –
About Definitive Healthcare
Services-Prepackaged Software, SIC 7372
Definitive Healthcare Corp. provides a healthcare commercial intelligence platform that delivers data, analytics, and insights across the healthcare ecosystem. The company offers subscription-based access to comprehensive intelligence on healthcare providers, facilities, physicians, and organizations. Its platform enables clients to analyze market trends, optimize commercial strategies, identify key decision-makers, and enhance sales and marketing operations within the complex healthcare industry. Definitive Healthcare serves diverse commercial clients, including biopharmaceutical companies, medical device manufacturers, healthcare information technology firms, healthcare providers, and various professional services organizations that sell into or navigate the healthcare sector.
The company operates primarily within the United States while serving customers and tracking data across various international markets. Definitive Healthcare maintains its corporate headquarters in Framingham, Massachusetts.
Summary of the business section of Definitive Healthcare's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Definitive Healthcare Corp.
- Headquarters
- Framingham, MA
- Address
- 492 Old Connecticut Path, Suite 401 01701
- Phone
- (508) 720-4224
- Website
- definitivehc.com
- Employees
- 686, Dec 31, 2025
- Industry
- Services-Prepackaged Software
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Boston, MA
Stock & identifiers
- Ticker
- DH
- Exchange
- Nasdaq
- IPO date
- Sep 16, 2021
- Shares outstanding
- 107M, Aug 6, 2026
- Public float
- $153.80M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 1861795
- CUSIP
- 24477E103
- ISIN
- US24477E1038
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Clay Brian Ritchey | Chief Executive Officer, Director | 5,000 |
| Kevin Coop | Chief Executive Officer, Director | 4,975,229 |
| Casey Heller | Chief Financial Officer | 1,798,502 |
| Jonathan Paris | Chief Legal Officer | 872,263 |
| Benjamin Graboske | EVP, Chief Data Officer | 1,312,027 |
| Kate Marie Shamsuddin | CHIEF OPERATING OFFICER | 694,149 |
| Richard Douglas Booth | CHIEF FINANCIAL OFFICER | 652,630 |
| William Moschella | Chief Product & Tech Officer | 451,302 |
| Jason Ronald Krantz | Director | 2,089,272 |
| Samuel A. Hamood | Director | 340,978 |
| Scott G. Stephenson | Director | 313,314 |
| Sastry Chilukuri | Director | 315,984 |
| Kathleen A. Winters | Director | 308,982 |
| Jill Larsen | Director | 114,751 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Coop | $8.60M | $5.30M | $3.70M | $26 | – |
| FY2024 Coop | $10.88M | $7.72M | $4.55M | $37 | – |
| FY2024 Krantz | $10.36M | $424.31K | $4.55M | $37 | – |
| FY2024 Musslewhite | $6.81M | -$4.68M | $4.55M | $37 | – |
| FY2023 Musslewhite | $8.43M | $3.15M | $2.81M | $90 | – |
| FY2022 Krantz | $820.93K | -$10.36M | $2.39M | $25 | $45 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, our workforce included 686 employees — of whom 678 were employed full time.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 24, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 1, 2023 | Late filing | Notification of late filing |
| Sep 16, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Sep 15, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |